GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Daehan New Pharm Co Ltd (XKRX:054670) » Definitions » Revenue

Daehan New Pharm Co (XKRX:054670) Revenue : ₩200,963 Mil (TTM As of Mar. 2024)


View and export this data going back to 2002. Start your Free Trial

What is Daehan New Pharm Co Revenue?

Daehan New Pharm Co's revenue for the three months ended in Mar. 2024 was ₩48,260 Mil. Its revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩200,963 Mil. Daehan New Pharm Co's Revenue per Share for the three months ended in Mar. 2024 was ₩3,440.74. Its Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₩14,327.35.

Warning Sign:

Daehan New Pharm Co Ltd revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue per Share Growth Rate of Daehan New Pharm Co was -6.30% per year. During the past 3 years, the average Revenue per Share Growth Rate was 11.00% per year. During the past 5 years, the average Revenue per Share Growth Rate was 12.10% per year. During the past 10 years, the average Revenue per Share Growth Rate was 12.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, Daehan New Pharm Co's highest 3-Year average Revenue per Share Growth Rate was 25.50% per year. The lowest was -9.60% per year. And the median was 10.35% per year.


Daehan New Pharm Co Revenue Historical Data

The historical data trend for Daehan New Pharm Co's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Daehan New Pharm Co Revenue Chart

Daehan New Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 134,097.44 149,293.35 166,586.41 197,957.35 204,222.61

Daehan New Pharm Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51,519.36 52,881.14 49,206.33 50,615.78 48,259.86

Competitive Comparison of Daehan New Pharm Co's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Daehan New Pharm Co's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Daehan New Pharm Co's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Daehan New Pharm Co's Revenue distribution charts can be found below:

* The bar in red indicates where Daehan New Pharm Co's Revenue falls into.



Daehan New Pharm Co Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩200,963 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Daehan New Pharm Co  (XKRX:054670) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


Daehan New Pharm Co Revenue Related Terms

Thank you for viewing the detailed overview of Daehan New Pharm Co's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Daehan New Pharm Co (XKRX:054670) Business Description

Traded in Other Exchanges
N/A
Address
1062-4 Namhyeon-dong, Gwanak-gu, Seoul, KOR, 137-851
Daehan New Pharm Co Ltd is a South Korea based company operating in the pharmaceutical sector. It is engaged in producing pharmaceutical products, animal health and nutrition, and bio products. The pharmaceutical products are tertan tab, amloc tab, tarocin SR tab, NP star tab and others. The animal health and nutrition products are starvac, pigcoc for calves, ocean doctor, and others. The bio range of the products by the group are CELRENA serum-free, BMPro serum-free, BMPro-V serum-free, ALyS505NK-EX serum-free and others.

Daehan New Pharm Co (XKRX:054670) Headlines

No Headlines